0000950138-05-000027.txt : 20120628
0000950138-05-000027.hdr.sgml : 20120628
20050114155418
ACCESSION NUMBER: 0000950138-05-000027
CONFORMED SUBMISSION TYPE: SC 13D/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050114
DATE AS OF CHANGE: 20050114
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: ROTH MICHAEL
CENTRAL INDEX KEY: 0001010207
FILING VALUES:
FORM TYPE: SC 13D/A
BUSINESS ADDRESS:
BUSINESS PHONE: 4142411810
MAIL ADDRESS:
STREET 1: 10556 N PORT WASHINGTON RD
CITY: MEQUON
STATE: WI
ZIP: 53092
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: WORLD HEART CORP
CENTRAL INDEX KEY: 0001024520
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13D/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-50628
FILM NUMBER: 05530785
BUSINESS ADDRESS:
STREET 1: 1 LASER STREET
STREET 2: OTTAWA
CITY: ONTARIO CANADA
STATE: A6
ZIP: K2E 7V1
BUSINESS PHONE: 6132374278
MAIL ADDRESS:
STREET 1: 1 LASER STREET
STREET 2: OTTAWA
CITY: ONTARIO CANADA
STATE: A6
ZIP: K2E 7V1
SC 13D/A
1
jan13d-worldheart.txt
\ROTH-STARK\2005 FILINGS\JAN 13D-WORLD HEART\
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN THE STATEMENTS FILED PURSUANT TO RULES 13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
(Amendment No. 1)*
World Heart Corporation
-----------------------
(Name of Issuer)
Common Stock, no par value per share
------------------------------------
(Title of Class of Securities)
980905
--------------
(CUSIP Number)
Todd Turall, Esq.
c/o SF Capital Partners Ltd.
3600 South Lake Drive
St. Francis, WI 53235
(414) 294-7000
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
December 31, 2004
-----------------
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box: [ ]
Note. Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k)
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
-----------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) or 2(e)
[ ]
-----------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
-----------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
--------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 4,314,875 shares of common stock
--------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 0
--------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH 4,314,875 shares of common stock
-----------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,314,875 shares of common stock
-----------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
-----------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
22.0%
-----------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
-----------------------------------------------------------------------------
Item 1. Security and Issuer.
This Amendment No. 1 to Schedule 13D relates to shares of common stock, no par
value per share (the "Common Stock") of World Heart Corporation (the "Issuer").
The principal executive office of the Issuer is 1 Laser Street, Ottawa, Ontario,
Canada A6 K2E 7V1.
Item 2. Identity and Background.
(a) This Amendment No. 1 to Schedule 13D is filed on behalf of Michael A. Roth
and Brian J. Stark (collectively, the "Reporting Persons").
(b) The principal place of business of the Reporting Persons is 3600 South Lake
Drive, St. Francis, WI 53235.
(c) See Item 5.
(d) Neither of the Reporting Persons has, during the past five years, been
convicted in any criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) Neither of the Reporting Persons has, during the past five years, been a
party to a civil proceeding of a judicial or administrative body of competent
jurisdiction, as a result of which any of them became or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
(f) The Reporting Persons are citizens of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration.
SF Capital (as defined below) utilized its available net assets to purchase the
securities referred to in this Schedule. The total amount of the funds to make
the purchases described in Item 5 was $5,000,000.
Item 4. Purpose of Transaction.
The Reporting Persons intend to continue to evaluate the performance of their
Common Stock as an investment in the ordinary course of business.
Item 5. Interest in Securities of the Issuer.
(a)(b) The Reporting Persons currently beneficially own an aggregate of
4,314,875 shares of Common Stock, or 22.0% of the outstanding shares of Common
Stock, which the Company has indicated to be 15,744,522 shares as of September
30, 2004, plus 1,600,000 shares of Common Stock issuable pursuant to the
conversion of debentures beneficially owned by the Reporting Persons, plus
2,291,244 shares of Common Stock pursuant to the exercise of warrants
beneficially owned by the Reporting Persons. On November 4, 2004, the Reporting
Persons inadvertently reported beneficial ownership of an additional 400,000
shares of Common Stock issuable pursuant to the conversion of debentures
beneficially owned by the Reporting Persons that were not in fact beneficially
owned. In addition, since November 4, 2004, the Reporting Persons have disposed
of an aggregate of 267,613 shares of Common Stock in open market transactions.
All of the foregoing represents securities held directly by SF Capital Partners
Ltd. ("SF Capital"). The Reporting Persons are the Managing Members of Stark
Offshore Management, LLC ("Stark Offshore"), which acts as investment manager
and has sole power to direct the management of SF Capital. Through Stark
Offshore, the Reporting Persons possess voting and dispositive power over all of
the foregoing shares. Therefore, for the purposes of Rule 13d-3 under the
Exchange Act, the Reporting Persons may be deemed to be the beneficial owners
of, but hereby disclaim such beneficial ownership of, the foregoing shares.
(c)(d)(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to
Securities of the Issuer.
Not applicable.
Item 7. Material to be Filed as Exhibits.
Exhibit 1 - Joint Filing Agreement.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: January 14, 2005
/s/ Michael A. Roth
--------------------------------
Michael A. Roth
/s/ Brian J. Stark
--------------------------------
Brian J. Stark
Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934,
as amended, the undersigned agree to the joint filing on behalf of each of them
of a statement on Amendment No. 1 to Schedule 13D (including amendments thereto)
with respect to 4,314,875 shares of Common Stock of World Heart Corporation and
further agree that this Joint Filing Agreement shall be included as an exhibit
to such joint filings.
The undersigned further agree that each party hereto is responsible for the
timely filing of such Amendment No. 1 to Schedule 13D and any amendments
thereto, and for the completeness and accuracy of the information concerning
such party contained therein; provided, however, that no party is responsible
for the completeness or accuracy of the information concerning any other party
making the filing, unless such party knows or has reason to believe that such
information is inaccurate.
IN WITNESS WHEREOF, the parties have executed this Joint Filing Agreement
on January 14, 2005.
/s/ Michael A. Roth
--------------------------------
Michael A. Roth
/s/ Brian J. Stark
--------------------------------
Brian J. Stark